Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995) (Q73462128)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

meta-analysis

0 references

title

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

main subject

lymphoblastic leukemia

1 reference

L B Silverman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L Declerck

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R D Gelber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

V K Dalton

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

B L Asselin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R D Barr

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L A Clavell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C A Hurwitz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Moghrabi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Y Samson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M A Schorin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J M Lipton

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H J Cohen

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S E Sallan

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

2247-2256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187916%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2401980

4 November 2019

exact match

0 references

cites work

Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Induction failure in acute lymphoblastic leukemia of childhood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Comparative pharmacokinetic studies of three asparaginase preparations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Comparative results of two intensive treatment programs for childhood acute lymphoblastic leukemia: The Berlin-Frankfurt-Münster and Dana-Farber Cancer Institute protocols

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Second malignancies in patients treated for childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Second neoplasms after acute lymphoblastic leukemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Ital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401980

7 January 2021